pramipexole has been researched along with lactoferrin in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (lactoferrin) | Trials (lactoferrin) | Recent Studies (post-2010) (lactoferrin) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 6,692 | 280 | 2,310 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Baky, NA; Al-Najjar, AH; Elariny, HA; Mohammed, AA; Sallam, AS | 1 |
1 other study(ies) available for pramipexole and lactoferrin
| Article | Year |
|---|---|
Pramipexole and Lactoferrin ameliorate Cyclophosphamide-Induced haemorrhagic cystitis via targeting Sphk1/S1P/MAPK, TLR-4/NF-κB, and NLRP3/caspase-1/IL-1β signalling pathways and modulating the Nrf2/HO-1 pathway.
Topics: Animals; bcl-2-Associated X Protein; Caspase 1; Caspase 3; Cyclophosphamide; Cystitis; Cytokines; Inflammation; Interleukin-6; Lactoferrin; Male; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pramipexole; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |